Evidence map›Paper›PMID 41048441›Full record

ArticleFrontiers in endocrinology2025

The aldosteronoma resolution score predicts the prognosis of hypertension under two surgical procedures.

Yifan Huang, Qianhao Huang, Yijie Xie, Chaoyue Ouyang, Yuedong Chen, Chao Huang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yifan Huang *The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Qianhao Huang *The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yijie XieThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Chaoyue OuyangThe Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yuedong ChenThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Chao HuangThe Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary aldosteronism (PA) is a leading cause of secondary hypertension, and aldosterone-producing adenoma (APA) is the most prevalent subtype. Surgical intervention is the primary treatment modality. However, a subset of patients fails to achieve normotension postoperatively. The Aldosteronoma Resolution Score (ARS), a preoperative predictive model, was used to forecast postoperative hypertension resolution. This study aims to validate the accuracy of the ARS in predicting hypertension resolution in Asian patients undergoing different surgical approaches. Methods: We conducted a retrospective review of 129 patients diagnosed with APA who underwent adrenal surgery. After excluding patients with incomplete data or insufficient follow-up, 83 patients were included in the analysis. Patients were stratified into two groups based on surgical approach: partial adrenalectomy and total adrenalectomy. Clinical and blood pressure data were collected at baseline and 6 months postoperatively. Results: At the 6-month follow-up, 62.65% (52/83) of patients achieved normotension without medication, while 37.35% (31/83) required continued antihypertensive therapy. Multivariate logistic regression analysis identified that patients achieving complete hypertension resolution were significantly more likely to have: preoperative use of ≤2 antihypertensive medications, hypertension duration ≤6 years, and BMI ≤25 kg/m². The predictive accuracy of the ARS, evaluated using the area under the receiver operating characteristic curve (AUC), was 0.866 for the overall cohort. Among the 49 patients (59.0%) who underwent partial adrenalectomy, 36.73% required antihypertensive medication, with an ARS AUC of 0.839. Among the 34 patients (41.0%) who underwent total adrenalectomy, 61.76% achieved normotension, with an ARS AUC of 0.897. No significant difference was observed in postoperative blood pressure outcomes between the two surgical approaches ( Conclusion: Our study validates the ARS, originally derived from Western populations, as a reliable preoperative predictor of hypertension resolution following adrenalectomy in Asian patients with APA. Furthermore, both partial and total adrenalectomy demonstrated comparable efficacy in achieving blood pressure control. These findings support the broad applicability of the ARS across diverse patient populations and surgical approaches.

Indexed as

AdenomaAdrenal Cortex NeoplasmsAdrenalectomyAdrenocortical AdenomaHyperaldosteronismHypertensionAdultAgedAldosteroneFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesAldosteroneAldosteronoma Resolution Score (ARS)hypertension resolutionpartial adrenalectomyprimary aldosteronismtotal adrenalectomy

Identifiers

PMID41048441
PMCPMC12491025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.